First Trust Health Care AlphaDEX Fund (FXH)

Key Metrics

TER 61.00% per year

Distribution policy Distributing

Fund size USD 927 M

Inception date May 8, 2007

Holdings 78

Fund currency USD

Fund domicile US

Provider First Trust

For full official fund details, factsheets, and holdings, visit ftportfolios.com (opens in new tab).

Historical Return

Last updated: Jun 15, 2026

1 Year +14.8% +0.8% Div

3 Years (avg.) +3.0% +0.8% Div

5 Years (avg.) +0.3% +0.8% Div

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

15.06% 1 Year

14.91% 3 Years

16.24% 5 Years

18.32% 10 Years

Max Drawdown

-12.35% 1 Year

-17.78% 3 Years

-29.72% 5 Years

-30.61% 10 Years

Sharpe Ratio

0.62 1 Year

-0.03 3 Years

-0.17 5 Years

0.24 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026

	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2011	4.5%	11.6%	21.7%	22.7%	17.8%	13.9%	14.9%	12.5%	13.7%	15.1%	15.2%	12.7%	11.3%	10.4%	10.3%
2012		19.2%	31.3%	29.5%	21.4%	15.9%	16.7%	13.7%	14.9%	16.3%	16.3%	13.5%	11.9%	10.8%	10.7%
2013			44.7%	35.0%	22.1%	15.1%	16.2%	12.8%	14.3%	16.0%	16.0%	12.9%	11.2%	10.2%	10.1%
2014				26.0%	12.2%	6.7%	10.0%	7.3%	9.9%	12.4%	12.8%	9.9%	8.4%	7.5%	7.6%
2015					0.0%	-1.8%	5.1%	3.1%	7.0%	10.2%	11.1%	8.0%	6.6%	5.8%	6.1%
2016						-3.6%	7.8%	4.2%	8.8%	12.4%	13.0%	9.2%	7.4%	6.5%	6.7%
2017							20.6%	8.2%	13.3%	16.8%	16.7%	11.5%	9.1%	7.8%	7.9%
2018								-2.8%	9.8%	15.5%	15.7%	9.7%	7.3%	6.1%	6.4%
2019									24.0%	26.0%	22.7%	13.1%	9.4%	7.6%	7.8%
2020										28.0%	22.0%	9.7%	6.0%	4.6%	5.4%
2021											16.3%	1.6%	-0.4%	-0.5%	1.3%
2022												-11.3%	-7.9%	-5.6%	-2.1%
2023													-4.3%	-2.6%	1.2%
2024														-0.8%	4.0%
2025															9.2%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%

15%

1y 3y N/A N/A

0 - 5%

16%

1y 3y N/A N/A

5 - 10%

17%

1y 3y N/A N/A

10 - 15%

17%

1y 3y N/A N/A

15 - 20%

12%

1y 3y N/A N/A

20 - 30%

15%

1y 3y N/A N/A

30 - 40%

1y 3y N/A N/A

> 40%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

13%

1y 3y N/A N/A

0 - 10

1y 3y N/A N/A

10 - 15

10%

1y 3y N/A N/A

15 - 20

19%

1y 3y N/A N/A

20 - 25

18%

1y 3y N/A N/A

25 - 35

13%

1y 3y N/A N/A

35 - 50

13%

1y 3y N/A N/A

> 50

10%

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

15 - 30%

1y 3y N/A N/A

Fair (±15%)

1y 3y N/A N/A

Overvalued

15 - 30%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

> 60%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

0.0%

1y 3y N/A N/A

Small Cap

4.7%

1y 3y N/A N/A

Mid Cap

17.8%

1y 3y N/A N/A

Large Cap

70.8%

1y 3y N/A N/A

Mega Cap

6.6%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$79B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	0.72%	2.03%
Beta Indicates the relationship between the price performance of a share and the market.	0.75	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	29.92	28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-40.31	-
Profitable Companies	86%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	33.53	14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	4.77	8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	8.86	10.72

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	15.86	21.15
Enterprise Value to Revenue Enterprise value divided by revenue	4.7	8.72
Total Debt to Enterprise Value Total debt divided by enterprise value	0.17	0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	1.08	0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	7.57%	-6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	-21.4%	-117.9%
Return on Equity Equity divided by market cap.	12.32%	1.23%
Return on Assets Indicates a company's profitability in relation to its total assets.	5.27%	3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	12.39%	3.31%

Sectors

Manufacturing	63.1%
Health Care and Social Assistance	13.5%
Professional, Scientific, and Technical Services	8.8%
Finance and Insurance	6.6%
Wholesale Trade	3.2%
Information	0.9%
Healthcare	0.4%
Other	3.5%

Countries

United States	96.0%
Ireland	2.4%
Netherlands	1.6%
Other	0.1%

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

Total Investment

Weight

Organon & Co.

OGN - Manufacturing

Market Cap $3.53B

P/E Ratio 14.1

Dividends 0.6%

Total Investment $24.52M

Weight 2.64%

Loading details…

Pfizer Inc.

PFE - Manufacturing

Market Cap $143.74B

P/E Ratio 19.2

Dividends 6.8%

Total Investment $21.86M

Weight 2.36%

Loading details…

HCA Healthcare Inc

HCA - Health Care and Social Assistance

Market Cap $83.23B

P/E Ratio 12.8

Dividends 0.8%

Total Investment $21.53M

Weight 2.32%

Loading details…

Cardinal Health, Inc.

CAH - Wholesale Trade

Market Cap $51.94B

P/E Ratio 33.8

Dividends 0.9%

Total Investment $21.52M

Weight 2.32%

Loading details…

Ionis Pharmaceuticals Inc

IONS - Manufacturing

Market Cap $12.25B

P/E Ratio -37.4

Dividends 0.0%

Total Investment $21.51M

Weight 2.32%

Loading details…

Medpace Holdings Inc

MEDP - Professional, Scientific, and Technical Services

Market Cap $13.14B

P/E Ratio 28.4

Dividends 0.0%

Total Investment $21.35M

Weight 2.30%

Loading details…

Molina Healthcare Inc

MOH - Finance and Insurance

Market Cap $10.18B

P/E Ratio 53.0

Dividends 0.0%

Total Investment $21.3M

Weight 2.30%

Loading details…

Biogen Inc

BIIB - Manufacturing

Market Cap $29.02B

P/E Ratio 21.0

Dividends 0.0%

Total Investment $21.04M

Weight 2.27%

Loading details…

Incyte Corp.

INCY - Professional, Scientific, and Technical Services

Market Cap $19.62B

P/E Ratio 13.7

Dividends 0.0%

Total Investment $20.86M

Weight 2.25%

Loading details…

Natera Inc

NTRA - Health Care and Social Assistance

Market Cap $33.14B

P/E Ratio -144.7

Dividends 0.0%

Total Investment $20.77M

Weight 2.24%

Loading details…

Solventum Corp

SOLV

Market Cap $13.06B

P/E Ratio 9.2

Dividends 0.0%

Total Investment $19.99M

Weight 2.16%

Loading details…

Lilly(Eli) & Co

LLY - Manufacturing

Market Cap $1.03T

P/E Ratio 38.9

Dividends 0.6%

Total Investment $19.87M

Weight 2.14%

Loading details…

Acadia Healthcare Company Inc

ACHC - Health Care and Social Assistance

Market Cap $2.29B

P/E Ratio -2.0

Dividends 0.0%

Total Investment $19.5M

Weight 2.10%

Loading details…

Universal Health Services, Inc. - Ordinary Shares - Class B

UHS - Health Care and Social Assistance

Market Cap $8.84B

P/E Ratio 5.7

Dividends 0.6%

Total Investment $19M

Weight 2.05%

Loading details…

Penumbra Inc

PEN - Manufacturing

Market Cap $12.48B

P/E Ratio 72.8

Dividends 0.0%

Total Investment $18.97M

Weight 2.05%

Loading details…

Insmed Inc

INSM - Manufacturing

Market Cap $20.76B

P/E Ratio -17.4

Dividends 0.0%

Total Investment $18.55M

Weight 2.00%

Loading details…

Merck & Co Inc

MRK - Manufacturing

Market Cap $281.24B

P/E Ratio 31.5

Dividends 3.0%

Total Investment $17.25M

Weight 1.86%

Loading details…

AMGEN Inc.

AMGN - Manufacturing

Market Cap $182.21B

P/E Ratio 23.3

Dividends 2.9%

Total Investment $17.2M

Weight 1.86%

Loading details…

Sotera Health Co

SHC - Professional, Scientific, and Technical Services

Market Cap $4.51B

P/E Ratio 38.3

Dividends 0.0%

Total Investment $16.92M

Weight 1.82%

Loading details…

Perrigo Company plc

PRGO - Manufacturing

Market Cap $1.42B

P/E Ratio -0.8

Dividends 11.3%

Total Investment $16.81M

Weight 1.81%

Loading details…

Key Metrics

Compare similar ETFs

Historical Return

Risk & Analysis Metrics

Volatility

Max Drawdown

Sharpe Ratio

Return Triangle (Heatmap)

Distributions

Profit Margin Distribution

P/E Ratio Distribution

Discounted Cash Flow

Market Cap Size Distribution

Portfolio Concentration

Latest News

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Down as Much as 55% and Still Magnificent: 3 Dividend Stocks Worth Holding for a Lifetime

Pfizer Inc. (PFE) Q1 2026 Earnings Call Transcript

Average metrics of all companies in portfolio

Sectors

Countries

Stock Screener

Organon & Co.

Organon & Co.

Pfizer Inc.

Pfizer Inc.

HCA Healthcare Inc

HCA Healthcare Inc

Cardinal Health, Inc.

Cardinal Health, Inc.

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc

Medpace Holdings Inc

Medpace Holdings Inc

Molina Healthcare Inc

Molina Healthcare Inc

Biogen Inc

Biogen Inc

Incyte Corp.

Incyte Corp.

Natera Inc

Natera Inc

Solventum Corp

Solventum Corp

Lilly(Eli) & Co

Lilly(Eli) & Co

Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

Universal Health Services, Inc. - Ordinary Shares - Class B

Universal Health Services, Inc. - Ordinary Shares - Class B

Penumbra Inc

Penumbra Inc

Insmed Inc

Insmed Inc

Merck & Co Inc

Merck & Co Inc

AMGEN Inc.

AMGEN Inc.

Sotera Health Co

Sotera Health Co

Perrigo Company plc

Perrigo Company plc

Cookie Settings